Literature DB >> 15671665

Mesenchymal stem cells: biological characteristics and potential clinical applications.

Moustapha Kassem1.   

Abstract

Mesenchymal stem cells (MSC) are clonogenic, non-hematpoietic stem cells present in the bone marrow and are able to differentiate into multiple mesoderm-type cell lineages, for example, osteoblasts, chondrocytes, endothelial-cells and also non-mesoderm-type lineages, for example, neuronal-like cells. Several methods are currently available for isolation of the MSC based on their physical and physico-chemical characteristics, for example, adherence to plastics or other extracellular matrix components. Because of the ease of their isolation and their extensive differentiation potential, MSC are among the first stem cell types to be introduced in the clinic. Several studies have demonstrated the possible use of MSC in systemic transplantation for systemic diseases, local implantation for local tissue defects, as a vehicle for genes in gene therapy protocols or to generate transplantable tissues and organs in tissue engineering protocols. Before their widespread use in therapy, methods allowing the generation of large number of cells without affecting their differentiation potential as well as technologies that overcome immunological rejection (in case allogenic transplantation) must be developed.

Entities:  

Mesh:

Year:  2004        PMID: 15671665     DOI: 10.1089/clo.2004.6.369

Source DB:  PubMed          Journal:  Cloning Stem Cells        ISSN: 1536-2302


  55 in total

Review 1.  A chromatin perspective of adipogenesis.

Authors:  Melina M Musri; Ramon Gomis; Marcelina Párrizas
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

Review 2.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

3.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

Authors:  Adrian P Bracken; Nikolaj Dietrich; Diego Pasini; Klaus H Hansen; Kristian Helin
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

4.  Distinct membrane mechanical properties of human mesenchymal stem cells determined using laser optical tweezers.

Authors:  Igor Titushkin; Michael Cho
Journal:  Biophys J       Date:  2006-01-06       Impact factor: 4.033

5.  Modulation of cellular mechanics during osteogenic differentiation of human mesenchymal stem cells.

Authors:  Igor Titushkin; Michael Cho
Journal:  Biophys J       Date:  2007-08-03       Impact factor: 4.033

Review 6.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

7.  Are mesenchymal stromal cells from children resistant to apoptosis?

Authors:  H Dimitriou; Ch Perdikogianni; G Martimianaki; D M Choumerianou; J Pelagiadis; M Kalmanti
Journal:  Cell Prolif       Date:  2009-04-28       Impact factor: 6.831

8.  Cell and gene therapies for refractory epilepsy.

Authors:  Detlev Boison
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

9.  Low-Intensity Ultrasound (LIUS) as an Innovative Tool for Chondrogenesis of Mesenchymal Stem Cells (MSCs).

Authors:  So Ra Park; Byung Hyune Choi; Byoung-Hyun Min
Journal:  Organogenesis       Date:  2007-10       Impact factor: 2.500

10.  Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.

Authors:  Gaoying Ren; Tianfu Li; Jiang Quan Lan; Andrew Wilz; Roger P Simon; Detlev Boison
Journal:  Exp Neurol       Date:  2007-08-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.